Siani H, Cooper C, Maillard JY. Efficacy of “sporicidal” wipes against Clostridium difficile. Am J Infect Control. 2011;39:212-8
 Coia JE, Duckworth GJ, Edwards DI, Farrington M, Fry C, Humphreys H, Mallaghan C, Tucker DR. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect. 2006;63:1-44.
 Sattar SA, Bradley C, Kibbee R, Wesgate R, Wilkinson MA, Sharpe T, Maillard JY. Disinfectant wipes are appropriate to control microbial bioburden from surfaces: use of a new ASTM standard test protocol to demonstrate efficacy. J Hosp Infect. 2015;91:319-25.
 Center for Disease Control. 2017 National and state healthcare-associated infections progress report. CDC. 2017. https://www.cdc.gov/HAIs/data/archive/2017-HAIS-progress report.html. Accessed 27 Feb 2020.
 Navalkele BD, Chopra T. Bezlotoxumab. An emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection. Biologics: targets & therapy. 2018;12:11-21.
 Center for Disease Control. Biggest threats and data. CDC. 2019. https://www.cdc.gov/drugresistance/biggest-threats.html#cdiff. Accessed 27 Feb 2020.
 Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clinical Infectious Diseases. 2002; 34:346-53.
 Boyce JM. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect. 2007;65:50-4.
 Eckstein BC, Adams DA, Eckstein EC, Rao A, Sethi AK, Yadavalli GK, Donskey CJ. Reduction of Clostridium difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods. BMC Infect Diseases. 2007;7:61-6.
 Guerrero DM, Nerandzic MM, Jury LA, Jinno S, Chang S, Donskey CJ. Acquisition of spores on gloved hands after contact with the skin of patients with Clostridium difficile infection and with environmental surfaces in their rooms. Am J Infect Control. 2012;;40:556-8.
 Shams AM, Rose LJ, Edwards JR, Cali S, Harris AD, Jacob JT, LaFae A, Pineles LL, Thom KA, McDonald LC, Arduino MJ. Assessment of the overall and multidrug-resistant organism bioburden on environmental surfaces in healthcare facilities. Infection Control & Hosp Epidemiol. 2016;37:1426-32.
 Rashid T, Haghighi F, Hasan I, Bassères E, Alam MJ, Sharma SV, Lai D, DuPont HL, Garey KW. Activity of hospital disinfectants against vegetative cells and spores of Clostridioides difficile embedded in biofilms. Antimicrobial Agents and chemotherapy. 2019. doi: 10.2147/BTT.S127099..
 Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infectious Diseases. 2006;6:130-7.  Fawley WN, Underwood S, Freeman J, Baines SD, Saxton K, Stephenson K, Owens RC, Wilcox MH. Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains. Infect Control & Hosp Epidemiol. 2007:28:920-5.
 Yokoe DS, Anderson DJ, Berenholtz SM, Calfee DP, Dubberke ER, Eilingson KD, Gerding DN, Haas JP, Kaye KS, Klompas M, Lo E. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control & Hosp Epidemiol. 2014:35(:21-31.
 Wiemken TL, Curran DR, Pacholski EB, Kelley RR, Abdelfattah RR, Carrico RM, Ramirez JA. The value of ready-to-use disinfectant wipes: compliance, employee time, and costs. Am J Infect Control. 2014:42:329-30.
 Ferreira AM, Andrade DD, Rigotti MA, Almeida MT, Guerra OG, Santos Junior AG. Assessment of disinfection of hospital surfaces using different monitoring methods. Revista Latino-Americana de Enfermagem. 2015;23:466-74.
 Wagers KJ, inventor; SC Johnson, Son Inc, assignee. All purpose cleaner with low organic solvent content. United States patent US 6,384,010. 2002. .
 Mitra S, Simon RE, Scott WB, Vieira K, Shaffer GA, inventors; Clorox Co, assignee. Bactericidal cleaning wipe. United States patent US 6,673,761. 2004.
 Napolitano LA, Monticello MV, Blank R, Odame G, inventors; Professional Disposables International Inc, assignee. Quaternary Ammonium Glycol Ether Disinfectant Wipes. United States patent application US 12/849,577. 2012 .
 Sattar SA, Bradley C, Kibbee R, Westgate R, Wilkinson MAC, Sharpe T, Maillard JY. Disinfectant wipes are appropriate to control microbial bioburden from surfaces: use of a new ASTM standard test protocol to demonstrate efficacy. J Infect Control 2015:91:319-25.
 Lineback CB, Nkemngong CA, Wu ST, Li X, Teska PJ, Oliver HF. Hydrogen peroxide and sodium hypochlorite disinfectants are more effective against Staphylococcus aureus and Pseudomonas aeruginosa biofilms than quaternary ammonium compounds. Antimicrob Resist Infect Control. 2018;7:154. doi: 10.1186/s13756-018-0447-5
 Nobile CG, Montuori P, Diaco E, Villari P. Healthcare personnel and hand decontamination in intensive care units: knowledge, attitudes, and behaviour in Italy. J Hosp infect. 2002;51:226-32.
 Shrestha SK, Sunkesula VC, Kundrapu S, Tomas ME, Nerandzic MM, Donskey CJ. Acquisition of Clostridium difficile on hands of healthcare personnel caring for patients with resolved C. difficile infection. Infect control Hosp Epidemiol. 2016 ;37:475-7.
 Chowdhury D, Rahman A, Hu H, Jensen SO, Deva AK, Vickery K. Effect of disinfectant formulation and organic soil on the efficacy of oxidizing disinfectants against biofilms. J Hosp Infection. 2019;103:33-41.
 Becker B, Henningsen L, Paulmann D, Bischoff B, Todt D, Steinmann E, Steinmann J, Brill FH, Steinmann J. Evaluation of the viricidal efficacy of disinfectant wipes with a test method simulating practical conditions. Antimicrobial Resistance & Infection Control. 2019;8:121.
 Environmental Protection Agency. Procedure for the OECD quantitative method for testing antimicrobial products against spores of Clostridium difficile (ATCC 43598) on inanimate, hard, non-porous surfaces. EPA 2017. https://www.epa.gov/sites/production/files/2017-09/documents/mb-31-final.pdf. Accessed 27 Feb 2020.
 Environmental Protection Agency. EPA MLB SOP-MB-31: Procedure for the OECD Quantitative Method for Testing Antimicrobial Products against Spores of Clostridium difficile (ATCC 43598) on Inanimate, Hard, Non-porous Surfaces. EPA 2017. https://www.epa.gov/sites/production/files/2017-12/documents/mb-31_december_2017.pdf Accessed 15 Oct 2020
 Environmental Protection Agency. EPA MLB SOP MB-28: Procedure for the Production and Storage of Spores of Clostridium difficile for Use in the Efficacy Evaluation of Antimicrobial Agents. EPA 2017. https://www.epa.gov/sites/production/files/2017-12/documents/mb-28_december_2017.pdf Accessed 15 Oct 2020
 Center for Disease Control. Biggest threats and data. CDC. 2010. https://www.cdc.gov/HAIs/pdfs/sir/national-SIR-Report_03_29_2012.pdf. Accessed 27 Feb 2020.
 Lopez GU, Kitajima M, Havas A, Gerba CP, Reynolds KA. Evaluation of a disinfectant wipe intervention on fomite-to-finger microbial transfer. Appl. Environ. Microbiol. 2014;80:3113-8.
 West AM, Nkemngong CA, Voorn MG, Wu T, Li X, Teska PJ, Oliver HF. Surface area wiped, product type, and target strain impact bactericidal efficacy of ready-to-use disinfectant Towelettes. Antimicrobial Resistance & Infect Control. 2018;7:122.
 Samore MH, Venkataraman L, DeGirolami PC, Arbeit RD, Karchmer AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Medicine. 1996;100:32-40.
 Mayfield JL, Leet T, Miller J, Mundy LM. Environmental control to reduce transmission of Clostridium difficile. Clinical Infectious Diseases. 2000;31:995-1000.
 Gingras G, Guertin MH, Laprise JF, Drolet M, Brisson M. Mathematical modeling of the transmission dynamics of Clostridium difficile infection and colonization in healthcare settings: a systematic review. PLoS One. 2016; doi: 10.1371/journal.pone.0163880.
 Cardoso CF, Faria JAF, Walter EHM. Modeling of sporicidal effect of hydrogen peroxide in the sterilization of low density polyethylene film inoculated with Bacillus subtilis spores. Food Ctrl. 2011;1559-64.
 Center for Disease Control. Disinfection and Sterilization. CDC. 2018. https://www.cdc.gov/infectioncontrol/guidelines/disinfection/index.html. Accessed 27 Feb 2020.
 Gonzalez EA, Nandy P, Lucas AD, Hitchins VM. Ability of cleaning-disinfecting wipes to remove bacteria from medical device surfaces. Am J Infect Control. 2015; 43:1331-5.
 Kenters N, Huijskens EG, de Wit SC, Sanders IG, van Rosmalen J, Kuijper EJ, Voss A. Effectiveness of various cleaning and disinfectant products on Clostridium difficile spores of PCR ribotypes 010, 014 and 027. Antimicrobial Resistance & Infection Control. 2017;6:54.
 Gold KM, Hitchins VM. Cleaning assessment of disinfectant cleaning wipes on an external surface of a medical device contaminated with artificial blood or Streptococcus pneumoniae. Am JInfect Control. 2013;41:901-7.
 Masuku SM, Babu D, Martin EM, Koo OK, O’Bryan CA, Crandall PG, Ricke SC. Cleaning and decontamination efficacy of wiping cloths and silver dihydrogen citrate on food contact surfaces. J Applied Microbiol. 2012;113:89-95.
 Center for Disease Control. Guideline for disinfection and sterilization in healthcare facilities. CDC. 2008. https://www.cdc.gov/infectioncontrol/guidelines/disinfection/efficacy.html. Accessed 27 Feb 2020.
 Rutala WA, Gergen MF, Weber DJ. Efficacy of different cleaning and disinfection methods against Clostridium difficile spores: importance of physical removal versus sporicidal inactivation. Infect Control HospEpidemiol. 2012;33:1255-8.
 Environmental Protection Agency. Methods and guidance for testing the efficacy of antimicrobial products against spores of Clostridium difficile on hard non-porous surfaces. EPA 2019.https://www.epa.gov/pesticide-registration/methods-and-guidance-testing-efficacy-antimicrobial-products-against-spores#products. Accessed 27 Feb 2020.